A recent study from the lab of Tanya Kalin, MD, Ph.D., professor of Child Health and Internal Medicine at the University of Arizona College of Medicine—Phoenix, has shown potential to improve therapeutic outcomes for patients ...
Bio & Medicine
Apr 16, 2024
0
3
Lung cancer is one of the most common cancers and has one of the lowest survival rates in the world. Cytokines, which are small signaling proteins, such as interleukin-12 (IL-12), have demonstrated considerable potential ...
Bio & Medicine
Feb 15, 2024
0
122
Cancer is characterized by a number of key biological processes known as the "hallmarks of cancer," which remodel cells and their immediate environment so that tumors can form, grow, and thrive. Many of these changes are ...
Bio & Medicine
Nov 2, 2022
0
57
Cancer is the second leading cause of death in Switzerland. Among the different types of cancers, non-small cell lung cancer (NSCLC) kills the most patients and remains largely incurable. Unfortunately, even newly approved ...
Cell & Microbiology
Oct 6, 2022
0
68
Scientists in the department of Advanced Organ Bioengineering and Therapeutics (Faculty of S&T, TechMed Centre) recently published a novel cancer immune therapy in the scientific journal Nature Communications. In their research, ...
Bio & Medicine
Aug 11, 2022
0
89
Researchers at Wake Forest School of Medicine have discovered that a nanoparticle therapeutic enhances cancer immunotherapy and is a possible new approach in treating malignant pleural effusion (MPE). MPE is the accumulation ...
Bio & Medicine
Dec 16, 2021
0
33
Scientists have reported a new approach to treating lung cancer with inhaled nanoparticles developed at Wake Forest School of Medicine, part of Wake Forest Baptist Health.
Bio & Medicine
Nov 14, 2019
0
141
The most common type of lung cancer, non-small cell lung cancer (NSCLC), continues to be difficult to treat, with five year survival rates of about 36 percent for stage 3A tumors. Jefferson College of Pharmacy researchers ...
Bio & Medicine
Apr 11, 2018
0
705
Most cancer deaths are caused by recurrent or metastatic tumors. Conventional therapies target rapidly dividing tumor cells, but are unable to eradicate the highly chemoresistant tumor initiating cells (TICs), ultimately ...
Biochemistry
Feb 7, 2018
0
7
Most tumors contain regions of low oxygen concentration where cancer therapies based on the action of reactive oxygen species are ineffective. Now, American scientists have developed a hybrid nanomaterial that releases a ...
Bio & Medicine
May 4, 2017
0
13
